CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

TFS HealthScience

Mike Mendoza, Executive Director, eClinical Technology Strategy and Biometrics

Innovating Clinical Trials Through Technology Strategy

Mike Mendoza

Mike Mendoza

Blending a sharp eye for innovation with deep expertise in clinical data, Mike Mendoza is redefining how global research teams harness technology for smarter, faster and more reliable clinical trials. As Executive Director at TFS HealthScience, he leads eClinical strategy and biometrics—bridging clinical operations with emerging technologies to streamline complex data processes and elevate quality across therapeutic areas.


Strategic Foresight in Clinical Research


Clinical trials demand precision, speed and trust. When lives depend on decisions made in real time, there is little room for fragmented systems or misaligned data. Mendoza has spent his career building the infrastructure that clinical development requires, but rarely has he been adaptive, cohesive and capable of keeping pace with science.


As Executive Director at TFS HealthScience, Mendoza works at the intersection of digital systems, data science and clinical operations. His role goes beyond technology deployment. It is about constructing a foundation where every digital move supports the broader scientific mission. In his hands, data becomes more than recordkeeping. It becomes a lens to see patterns earlier, reduce delays and ask better questions at every step of the trial.


His work in eClinical strategy reflects this principle. Rather than gathering data for compliance, he designs systems that interpret and contextualize it. This approach transforms trial information into something much rarer— insight that moves with the pace of discovery.


Designing for Agility and Accountability


Mendoza builds environments where adaptability is not an afterthought but a core feature. In an industry governed by regulatory scrutiny and rapid change, his teams are trained to anticipate obstacles before they surface. From platform design to data integrity, every system under his oversight is built for resilience.


At TFS, that discipline has delivered tangible results. His frameworks have shortened trial timelines, improved real-time visibility for sponsors and strengthened global alignment across operations. His impact reaches beyond the technical. It is visible in how teams work, how milestones are met and how complexity is managed without chaos.


Guiding People and Platforms Alike


Mendoza’s leadership is rooted in clarity and trust. He mentors emerging leaders in technology, decision-making and cross-functional thinking. His teams learn to see systems as more than tools—they become environments that shape how science is conducted and delivered.


During his tenure as Senior Director at CALYX, Mendoza refined his ability to scale technology across borders. He managed compliance, usability and platform integration across international teams, always focusing on how design choices affect outcomes on the ground.


What distinguishes him is not just technical fluency or project execution. He can align people and platforms toward the same goal—accelerating drug development with confidence and purpose.


Moving Clinical Trials from Systems to Ecosystems


At a time when data volume grows by the day and timelines continue to shrink, Mendoza brings order to complexity. He is as skilled in long-range platform strategy as in the granular decisions that define daily execution. His leadership is already reshaping how trials run at TFS, turning isolated tools into integrated ecosystems. The result is faster insights, fewer bottlenecks and better patient outcomes.


In Mendoza’s world, digital transformation is not jargon. It is a process with direction and discipline. As trials expand into new frontiers—oncology, rare diseases, personalized medicine—he ensures the data guiding those efforts is reliable and visionary.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/innovating-clinical-trials-through-technology-strategy-nwid-2517.html